FOR IMMEDIATE RELEASE: May 14, 2014
Christine Frey, AUA
AUA RELEASES NEW CLINICAL GUIDELINE ON THE EVALUATION AND TREATMENT OF CRYPTORCHIDISM
Linthicum, MD, May 14, 2014 — Discontinuing the use of ultrasound or other imaging modalities in the evaluation of boys with cryptorchidism, and no longer utilizing hormonal therapy to induce testicular descent are just two of 16 new clinical practice guideline statements on Cryptorchidism released today by the American Urological Association (AUA). This new clinical practice guideline, which will be presented during the 2014 AUA Annual Meeting in Orlando, FL, offers physicians and non-physician providers a consensus of principles and treatments plans for the management of cryptorchidism.
Cryptorchidism or undescended testis (UDT) is one of the most common pediatric conditions of the male endocrine glands and the most common genital condition at birth. Today’s standard of treatment in the United States is orchidopexy, or the surgical repositioning of the testis within the scrotal sac, while hormonal therapy, once a more accepted treatment option, has now fewer advocates for being as effective. Primary reasons for treatment of cryptorchidism include increased risks for fertility problems, testicular cancer, and testicular torsion or associated inguinal hernia.
Specific evaluation and treatment statements within the guideline include:
“Undescended testis is a relatively common condition that occasionally resolves without any intervention by the time a child is six months old,” said Julia S. Barthold, MD, who served as vice chair on the panel that developed the guideline. “Diagnosis and treatment of undescended testis has significantly evolved over the past half century and these new guidelines provide the best-available clinical direction for determining whether a testicle is present or absent and the most effective treatment methods.”
NOTE TO REPORTERS: Experts are available to discuss this study. To arrange an interview with an expert, please contact the AUA Communications Office at 410-689-3932 or e-mail cfrey@AUAnet.org.
About the American Urological Association: The 109th Annual Meeting of the American Urological Association takes place May 16 – 21 at the Orange County Convention Center in Orlando, FL.
Founded in 1902 and headquartered near Baltimore, Maryland, the American Urological Association is a leading advocate for the specialty of urology, and has more than 20,000 members throughout the world. The AUA is a premier urologic association, providing invaluable support to the urologic community as it pursues its mission of fostering the highest standards of urologic care through education, research and the formulation of health policy.